|1.||Ginsburg, Isaac: 5 articles (05/2011 - 01/2004)|
|2.||Melzer, Jörg: 3 articles (01/2013 - 02/2006)|
|3.||Saller, Reinhard: 3 articles (01/2013 - 02/2006)|
|4.||Aslam, Muhammad Nadeem: 2 articles (11/2010 - 03/2005)|
|5.||Varani, James: 2 articles (11/2010 - 03/2005)|
|6.||Brignoli, Reto: 2 articles (11/2006 - 02/2006)|
|7.||Ueberall, Florian: 2 articles (02/2006 - 09/2005)|
|8.||Fuchs, Dietmar: 2 articles (02/2006 - 09/2005)|
|9.||Radomska-Leśniewska, Dorota M: 1 article (01/2015)|
|10.||Jóźwiak, Jarosław: 1 article (01/2015)|
07/01/2005 - "Evidence also suggests that padma 28 is effective for intermittent claudication, although more data are required to confirm these findings. "
01/01/2013 - "Some evidence exists from individual trials to suggest that Padma 28 may be effective in increasing walking distances, at least in the short term (four months), in people with intermittent claudication. "
01/01/2013 - "The highest level of evidence for the use of Padma 28 was found in the indication of intermittent claudication (11 trials). "
01/01/2013 - "Randomised controlled trials of Padma 28 compared with placebo or other pharmacological treatments in people suffering from intermittent claudication. "
10/17/1994 - "In conclusion, our study has shown that treatment with Padma-28 over a four month period significantly increases the walking distance in patients with stable intermittent claudication of long duration."
02/01/2006 - "To give an overview of the complex efficacy profile of Padma 28, to review available data, to relate findings to the development of atherosclerosis and thus to discuss the antiatherogenic potential of Padma 28. "
01/01/1992 - "The possible mechanism by which Padma 28 may exert its anti-atherosclerotic action is discussed in the scope of the immunological theory of atherosclerosis."
01/01/1992 - "The effect of Padma 28 on selected parameters of humoral and cellular immune reactions in rabbits subjected to experimental atherosclerosis was studied. "
01/01/1992 - "Padma 28 modifies immunological functions in experimental atherosclerosis in rabbits."
01/01/2013 - "According to clinical evidence, Padma 28 has shown to be a safe and effective symptomatic treatment option for atherosclerosis-related diseases such as intermittent claudication. "
|3.||Chronic Hepatitis (Chronic Active Hepatitis)
06/01/2004 - "Tibetan herbal remedy PADMA 28 revealed promising results to support treatment of intermittent claudication, atherosclerosis and chronic hepatitis. "
09/02/2005 - "The Tibetan herbal remedy PADMA 28 revealed promising results to support treatment of atherosclerosis, Charot syndrome (intermittent claudication), chronic active hepatitis and infection of the respiratory tract. "
|4.||Wounds and Injuries (Trauma)
11/01/2010 - "The goal of the present study was to determine whether topical treatment of rat skin with PADMA 28 would improve skin structure/function, and whether subsequently induced abrasion wounds would heal more rapidly in skin that had been pretreated with PADMA 28. "
11/01/2010 - "A multi-component herbal preparation (PADMA 28) improves structure/function of corticosteroid-treated skin, leading to improved wound healing of subsequently induced abrasion wounds in rats."
11/01/2010 - "Abrasion wounds in skin that had been pretreated with PADMA 28 healed more rapidly than did wounds in Temovate plus DMSO-treated skin. "
|1.||Plant Preparations (Preparation, Plant)
|3.||Glutamic Acid (Glutamate)
|4.||1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
|6.||Amyloid (Amyloid Fibrils)
|9.||Intercellular Signaling Peptides and Proteins (Growth Factors)
|10.||Insulin-Like Growth Factor I (IGF-1)
|1.||Angioplasty (Angioplasty, Transluminal)
|2.||Drug Therapy (Chemotherapy)